As of November 2024 Kymera Therapeutics has a market cap of £2.42 Billion. This makes Kymera Therapeutics the world's 3505th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 4th, 2024 the market cap of Kymera Therapeutics was reported to be: